HC Wainwright Reiterates “Buy” Rating for 89bio (NASDAQ:ETNB)

89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They currently have a $31.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 166.32% from the company’s current price. A number of other […]

Leave a Reply

Your email address will not be published.

Previous post Keros Therapeutics (NASDAQ:KROS) Stock Rating Reaffirmed by Piper Sandler
Next post ZTO Express (Cayman) Inc. (NYSE:ZTO) Receives $32.00 Average Target Price from Brokerages